Security key
45258H106
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,769,253
- Total 13F shares
- 633,819
- Share change
- +233,023
- Total reported value
- $1,705,059
- Price per share
- $2.69
- Number of holders
- 17
- Value change
- +$653,633
- Number of buys
- 9
- Number of sells
- 7
Report period
Q2 2023
Institutions
17
Top holders
10
IMMX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.2%
|
105,357
|
$191,750 | — | 31 Mar 2023 | |
| UMB Bank, n.a. |
13F
|
Company |
0.19%
|
99,300
|
$180,726 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
79,722
|
$145,094 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
42,960
|
$78,187 | — | 31 Mar 2023 | |
| Moss Adams Wealth Advisors LLC |
13F
|
Company |
0.04%
|
20,078
|
$36,542 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
17,723
|
$32,256 | — | 31 Mar 2023 | |
| InterOcean Capital Group, LLC |
13F
|
Company |
0.03%
|
15,900
|
$28,938 | — | 31 Mar 2023 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.02%
|
10,692
|
$19,459 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,375
|
$12,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,301
|
$4,188 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
350
|
$637 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
38
|
$69 | — | 31 Mar 2023 | |
| Sean Senn |
3/4/5
|
Under 10% owner |
—
class O/S missing
|
899,800
|
$4,205,665 | — | 14 Jul 2022 | |
| Vladimir P. Torchilin |
3/4/5
|
Scientific Co-Founder |
—
class O/S missing
|
905,200
|
$4,230,905 | — | 20 Dec 2021 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q2 2023
As of 30 Jun 2023,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
633,819 shares.
The largest 10 holders included
Lynwood Capital Management Inc., VANGUARD GROUP INC, UMB Bank, n.a., GEODE CAPITAL MANAGEMENT, LLC, Koshinski Asset Management, Inc., STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, Moss Adams Wealth Advisors LLC, InterOcean Capital Group, LLC, and BlackRock Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
12
Q2 2023 holders
17
Holder diff
5
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.